NCT01489813 2025-02-05
Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment
Emory University
Phase 2 Completed
Clinical Trials
5 trialsNCT00118040 2021-06-10
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01325311 2016-08-03
Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00276835 2015-04-10
Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer
Northwestern University
Phase EARLY_PHASE1 Completed
NCT00001696 2008-03-04
A Pharmacokinetic Study of Genistein, a Tyrosine Kinase Inhibitor
National Institutes of Health Clinical Center (CC)
Phase 1 Completed